Optibiotix Health Share Discussion Threads

[diamond fibre] 07/12/2016 09:25

Do not worry boys,girls, at least two new deals will be done soon.

[judijudi] 07/12/2016 08:18

Couldn't help it

[owenmo] 06/12/2016 20:23

F3rdinand, . . . . and then there's 6. Skinbiotix (which you sort of alluded to) and 7. a treatment for Parkinson's disease. SOH won't be too disappointed if all chickens don't come home to roost - but I will be; call it greed? 7 out of 7 and nothing less. So let's call a spade a spade - it's a 7-bagger, minimum. And 2017 is about right. I'm logging this for a repeat and "told you so" post sometime next year.

[elrico] 06/12/2016 20:12

Indeed, Neft - TW have mentioned P&G at least twice over several months. I still believe they are involved. I would go as far as say I expect them to be the MN launching our first cardiovasculare product in spring 2017.

[mazzstar] 06/12/2016 20:12

To the person who downvoted every one of my comments today: do you have a crush on me or something?

[neftanikoff] 06/12/2016 19:38

parob, DSM yes, but you know very well P & G has been cited for a very long time, am i right ?

[riskybusiness1] 06/12/2016 18:50

One of the biggest opportunities is the ability to enhance the growth rate of specific microbes. The success of which has been shown recently. It swings open the door for deals right across the space From probiotic manufacturers to the animal feed markets. The dsm deal being a multi billion £ ingredient supplier gave opti early industry financial backing and its confidence. This targeted approach to improve the growth rate which can increase efficacy of a product is revolutionary. It gives the opportunity to not only use this tech to optimise Optis lpldl strain (which has already been shown) but many already on the market - starting with DSM. You can be pretty certain multiple deals with global players will materialise to optimise their products. Especially as the science is becoming clearer, giving more reasons for suppliers to use this tech to stay ahead of the curve. It Is jam tomorrow as this is still revolutionary science, the fact a deal such as this struck so early shows huge confidence in Optis tech.

[f3rdinand] 06/12/2016 17:39

Basically what we're saying here is that OPTI will pretty much have a slice of every pie in the next few years...

1. Food will contain OPTI's calorie free sugars.
2. The nation will be losing weight through OPTI's slimbiome 'revolution'.
3. Cardiovascular disease will be slashed with our supplements and most probably pharma products prescribed by the NHS in years to come.
4. Beauty products will be adapted to bring health benefits/ work better.
5. Wounds and infections will be diminished through our technology.

All massive markets...as others have rightly mentioned- all we need here is one MN deal and then the belief in the microbiome and thus in OPTI will increase tenfold. That's why i'm adding more while the wider market ignores our progress.

[mazzstar] 06/12/2016 17:29

Thank you someuwin ;) This could be exciting!

[someuwin] 06/12/2016 17:25

Good research mazz!

[mazzstar] 06/12/2016 17:25

parob nitpick my words why don't you. You should know what I mean by support and confidence behind the product and to spell it out for you since it's not clear enough I meant A CONFIRMED DEAL!

[mazzstar] 06/12/2016 17:23

I'm thinking shampoo I'm thinking Johnson & Johnson.

[mazzstar] 06/12/2016 17:14

I googled Cath O'Neill and came across a job that was posted 2 weeks ago. Interesting that it mentions the scalp, I wonder what Opti are up to...? 'Research Technician in Musculoskeletal and Dermatological Sciences. You will be engaged full time in research to investigate the microbiota of the scalp in healthy individuals and those with dandruff. This work will involve studying barrier markers in ex vivo skin innoculated with scalp microbiota, as a model system.
You will be part of a team which investigates skin barrier function in health and disease and how the microbiota interact with the epidermal barrier.
You must have at least a B.Sc in a biological science, or equivalent experience. Previous experience in the fields of skin biology or microbiology will be an advantage...Enquiries about the vacancy, shortlisting and interviews: Dr Cath O'Neill'
hxxps://www.totaljobs.com/job/research-technician/university-of-manchester-job67251745

[parob] 06/12/2016 17:08

Mazz, you've just said:"It's not even revenues we should be concerned about, it is industry confidence and support behind these products.""OptiBiotix Health plc (AIM: OPTI), a life sciences business developing products to tackle obesity, high cholesterol and diabetes, announces that it has entered into a joint development agreement with Royal DSM. The agreement allows for collaboration between both parties to develop new products using OptiBiotix's OptiBiotic(R) technology platform. Royal DSM is a global science based company active in health, nutrition and materials with approximately 25,000 employees and annual net sales in the region of EUR10 billion. Its Nutritional Products business is one of the world's leading suppliers of vitamins, carotenoids, nutritional lipids and other ingredients in the food, pharmaceutical and personal care industries."If that's not major industry backing, I don't know what is!

[mazzstar] 06/12/2016 17:05

true parob but support with £££; not just on paper

[parob] 06/12/2016 17:00

Yeah it's not like Royal DSM are a global multi-billion turnover over company....

[neftanikoff] 06/12/2016 16:58

Definitely the MN is needed and i also will be gobsmacked if this deal is not announced.

[mazzstar] 06/12/2016 16:54

Neftan, I appreciate that you agree with me about the MN. This time round we need to do better than Go Figure and I will be extremely disappointed in SOH if he's unable to deliver on the cholesterol product. I cannot stress how crucial it is to have a major player back this Science given we are in such a new field. It's not even revenues we should be concerned about, it is industry confidence and support behind these products. We've not had that yet and without it, the share price isn't going anywhere.

[neftanikoff] 06/12/2016 16:32

looks like some private investors have sold some (50 yesterday and 50 today), after all some pretty big hitters had said previously that they would give it to Christmas for news, actually one told us that he sold 100 of holding last week last. As for Mazzstar, he said more or less he was finished posting earlier this week (after 13 down ticks on a post detrimental to him), but he can't stop himself, i agree with him in as much we probably do need this long awaited MN to show it's credentials in order to stop the share price bleeding, either that or something else.

[monkeywench1] 06/12/2016 16:20

I see judi is coming around to my point of view.

[mazzstar] 06/12/2016 16:16

JH, calm down dear. Without an industry player behind the first major deal, there will be questions hanging over the science and potential of these products. That will affect the share price whether you want to admit or not.

[john henry] 06/12/2016 16:00

Mazzstar you talk an absolute load of tripe, the market is already discounting a lack of cholesterol news. Why do you think it's moved from 100p to 63p I'm guessing you have very little understanding of markets. I'm reluctant to filter peeps, but your constant repeated garbage has just got to be filtered.